Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Combination Therapy Between Hydroxy Urea, Omega 3, Nigella Sativa and Honey on Antioxidant-oxidant Status and Reduction of Iron Overload in Pediatric Major Thalassemia

NCT04292314 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT04292314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04292314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Combination Therapy Between Hydroxy Urea, Omega 3, Nigella Sativa and Honey on Antioxidant-oxidant Status and Reduction of Iron Overload in Pediatric Major Thalassemia
Lead sponsor
Beni-Suef University
Phase
Phase 2/3
Overall status
Completed
Start date
November 1, 2019
Completion date
January 20, 2021
Enrollment
350 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

iron overload, oxidative stress, thalassemia major